FDA Inspection 796516 — Amerisource Bergen Consulting Services, Inc.
The FDA completed an inspection of Amerisource Bergen Consulting Services, Inc. on August 28, 2012 in Frisco, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 28, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Frisco, TX (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)